Business & FinanceDealsHealth

At-home health test maker Thorne explores sale

21 July 2023, 6:41 pm 1 minute

Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale.

Market Impact

Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million. They are up 63.9% year-to-date, outperforming an 18.2% rise in the S&P 500 Index.

Article Tags

Topics of Interest: Business & FinanceDealsHealth

Type: Reuters Best

Sectors: Business & FinancePharmaceuticals & Healthcare

Regions: Americas

Countries: United States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Share this article

Work Email Address *

Country *

I'd like to receive communications about Reuters resources, events, products, or services.

(Please note you can manage and update your preferences at any time.) By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.

By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field

Work Email Address *

Country *

More of Reuters Best

JPMorgan CEO Jamie Dimon to visit Africa in growth push

At-home health test maker Thorne explores sale

Market Impact

More of Reuters Best

JPMorgan CEO Jamie Dimon to visit Africa in growth push

Ryanair raises summer fare outlook as ‘ugly scenario’ avoided

India flags cricket rights concerns with Disney-Reliance $8.5 bln merger

Custody giant State Street expands crypto services in new partnership